Regencell Bioscience (RGC) has had the highest return this year by a US stock in the Nasdaq Composite (IXIC), returning 527.6%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Regencell Bioscience (RGC) | 2025 | 527.56% |
Mobile-health Network Solutions Class A Ordinary Shares (MNDR) | 2025 | 458.95% |
MicroAlgo (MLGO) | 2025 | 419.27% |
Global Interactive Technologies (GITS) | 2025 | 406.22% |
Abits (ABTS) | 2025 | 371.79% |
Dominari (DOMH) | 2025 | 324.76% |
Lixiang Education (LXEH) | 2025 | 287.4% |
CervoMed (CRVO) | 2025 | 281.25% |
Oncology Institute (TOI) | 2025 | 272.55% |
Yoshiharu Global (YOSH) | 2025 | 271.52% |
Jiuzi (JZXN) | 2025 | 227.86% |
VivoPower International (VVPR) | 2025 | 196.3% |
Rapid Micro Biosystems (RPID) | 2025 | 190.11% |
Junee Limited Ordinary Shares (JUNE) | 2025 | 147.86% |
Oriental Culture Holding (OCG) | 2025 | 142.86% |
Chimerix (CMRX) | 2025 | 142.45% |
Jayud Global Logistics Limited Class A Ordinary Shares (JYD) | 2025 | 136.62% |
Niu Technologies (NIU) | 2025 | 126.67% |
Vasta Platform (VSTA) | 2025 | 126.5% |
Corcept Therapeutics (CORT) | 2025 | 125.64% |
Neuronetics (STIM) | 2025 | 123.03% |
Xunlei Ltd Adr (XNET) | 2025 | 120.1% |
Jiayin (JFIN) | 2025 | 118.44% |
Reborn Coffee (REBN) | 2025 | 115.79% |
DatChat (DATS) | 2025 | 113.26% |
